Focus:
Anesthesia & Respiratory
-
6 May 2020 Analysis
ResMed: providing remote care for long-term ventilator users
California-headquartered ResMed creates devices to help treat respiratory conditions like sleep apnoea and chronic obstructive pulmonary disease (COPD). In the wake of Covid-19, it has accelerated the release of its...
-
14 April 2020 Comment
Demand far outstrips the supply of N95 respirators
Due to global shortages, 3M Co has ramped up its production of N95 respirators, doubling its normal output. The company is currently manufacturing 100 million N95 respirators per month worldwide,...
-
20 February 2020 News
US researchers develop heart valve designed to grow with children
A new type of heart valve could remove the need for children with congenital heart disease to undergo multiple open-heart surgeries by growing alongside them.
-
20 February 2020 Comment
Positive airway pressure device market to reach $3.5bn by 2028
Due to the shift of care from hospital to home and increasing prevalence of obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD), the global market value for positive...
-
17 February 2020 News
Teleflex issues global recall of COMFORT FLO Humidification system
Teleflex, a medical device company focused on critical care and surgery, has issued a worldwide voluntary recall of COMFORT FLO Humidification system.
-
19 December 2019 Analysis
A diagnostic tool for respiratory disease: machine learning coughs up
ResApp uses machine-learning algorithms to analyse cough sounds and diagnose conditions such as asthma, pneumonia and bronchiolitis from a smartphone. Natalie Healey speaks to creator Professor Udantha Abeyratne to find...
-
12 December 2019
Israeli health tech firms merge to advance AI-powered biomarkers
Israel-based artificial intelligence (AI) startups Beyond Verbal and Healthymize, which both make diagnoses through voice analyses, have merged operations to create an entity, Vocalis Health.
-
10 December 2019 News
FDA approves Aptar’s acute repetitive seizures treatment device
The US Food and Drug Administration (FDA) has approved Aptar Group’s Unidose Liquid System to treat acute repetitive seizures in those with epilepsy.
-
20 November 2019 Analysis
Mouth Cancer Action Month: quick, accurate, cheap diagnosis
Around 60,000 people in the UK will be diagnosed with an oral cancer over the next decade and around 30,000 will die. Early diagnosis can greatly improve the prospects of...
-
19 November 2019 News
Biofourmis signs agreement to acquire Biovotion
US-based digital therapeutics company Biofourmis has signed an agreement to acquire Switzerland-based Biovotion, a developer of a clinical-grade wearable biosensor platform.